medigraphic.com
SPANISH

Revista de la Facultad de Medicina UNAM

  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2026, Number 2

<< Back Next >>

Rev Fac Med UNAM 2026; 69 (2)

Primary Breast Chondrosarcoma: A Case Report and Review of the Literature

Santiago-Sanabria L, Llano-Tostado A, Sanabria-Villegas LC, Iturralde-Rosas PP, Molina-Pérez CJ
Full text How to cite this article

Language: Spanish
References: 38
Page: 39-51
PDF size: 268.62 Kb.


Key words:

Breast cancer, mammary chondrosarcoma, extraskeletal chondrosarcoma, mammary sarcoma, immunohistochemistry.

ABSTRACT

Primary chondrosarcoma of the breast is an exceedingly rare neoplasm, with only a limited number of cases reported in international medical literature. In the present article, we describe the case of a 65-year-old woman with no relevant past medical history who presented to the breast clinic with a palpable breast mass of six months’ duration.
Mammography was requested as the initial imaging modality, revealing an irregular, spiculated, hyperdense mass located in the upper outer quadrant of the left breast. Complementary breast ultrasonography identified two irregular, spiculated nodules with a combined size of 2.2 cm. The lesion was classified as BI-RADS 5. Subsequently, a core needle biopsy was performed. Histological examination demonstrated a high-grade mesenchymal neoplasm characterized by marked cellularity, significant cytologic atypia, and the presence of chondrocytes with abundant eosinophilic cytoplasm, hyperchromatic pleomorphic nuclei, and anaplastic cells, findings consistent with a primary chondrosarcoma of the breast.
Considering the histological grade and tumor size, the lesion was classified as stage II according to the breast sarcoma staging system. After discussion in a multidisciplinary breast tumor board, a total mastectomy was performed due to the aggressive nature of the tumor and its poor prognostic features. Adjuvant treatment with external beam radiotherapy directed to the chest wall was administered with the aim of achieving local disease control. During follow-up, the patient has remained free of recurrence during the 6 months following completion of treatment.
Breast chondrosarcomas represent a rare spectrum of breast tumors that predominantly affect postmenopausal women. Clinically, they usually present as a palpable mass, underscoring the importance of diagnostic mammography and histological confirmation through biopsy. Immunohistochemical markers such as S100 protein and vimentin play a crucial role in reaching the diagnosis. The surgical approach remains the cornerstone of treatment. The role of adjuvant therapies remains controversial; therefore, treatment decisions should be individualized on a case-by-case basis.


REFERENCES

  1. International Agency for Research on Cancer. GLOBOCAN 2022: Mexico fact sheet [Internet]. Lyon (FR):IARC; 2024 [cited 2026 Jan 15]. Available from: https://tinyurl.com/2dlqf4x4

  2. Lee JS, Yoon K, Onyshchenko M. Sarcoma of the breast: clinicalcharacteristics and outcomes of 991 patients from theNational Cancer Database. Sarcoma. 2021;2021:8828158.https://doi.org/10.1155/2021/8828158

  3. Lahat G, Lazar A, Lev D. Sarcoma epidemiology andetiology: potential environmental and genetic factors.Surg Clin North Am. 2008;88(3):451-481. https://doi.org/10.1016/j.suc.2008.03.001

  4. Sharma S, Sharma A, Lobo A, Sampat NY, Kumar M,Kajla R, Mohapatra SS, Mohanty SK. Primary extraskeletalmyxoid chondrosarcoma of the breast: report of a caseand literature review. Pathologica. 2022;114(3):228-237.https://doi.org/10.32074/1591-951X-303

  5. Agrawal S, Chowdhury Z, Paul P, Mandal T. A rare caseof primary chondrosarcoma of the breast: a case report andcomprehensive literature review. Discoveries (Craiova).2024;12(3). https://doi.org/10.15190/d.2024.12

  6. Flegg KM, Flaherty JJ, Bicknell AM, Jain S. Surgicaloutcomes of borderline breast lesions detected by needlebiopsy in a breast screening program. World J Surg Oncol.2010;8:78. https://doi.org/10.1186/1477-7819-8-78

  7. Chow WA. Chondrosarcoma: biology, genetics, and epigenetics.F1000Res. 2018;7:F1000 Faculty Rev-1826. https://doi.org/10.12688/f1000research.15953.1

  8. Rakha EA, Tan PH, Shaaban A, Tse GM, Esteller FC,van Deurzen CHM, et al. Do primary mammary osteosarcomaand chondrosarcoma exist? A review of a largemulti-institutional series of malignant matrix-producingbreast tumours. Breast. 2013;22(1):13-18. https://doi.org/10.1016/j.breast.2012.09.010

  9. Nazeri E, Gouran Savadkoohi M, Majidzadeh AK, EsmaeiliR. Chondrosarcoma: an overview of clinical behavior,molecular mechanisms mediated drug resistance andpotential therapeutic targets. Crit Rev Oncol Hematol.2018;131:102-109. https://doi.org/gj3b4m

  10. WHO Classification of Tumours Editorial Board. WHOclassification of tumours: soft tissue and bone tumours.5th ed. Vol. 3. Lyon (FR): International Agency for Researchon Cancer; 2020. Available from: https://tinyurl.com/2cfyanh5

  11. Kennedy T, Biggart J. Sarcoma of the breast. Br J Cancer.1967;21(4):635-644. https://doi.org/10.1038/bjc.1967.76

  12. Beltaos E, Banerjee TK. Chondrosarcoma of the breast:report of two cases. Am J Clin Pathol. 1979;71(3):345-349.https://doi.org/10.1093/ajcp/71.3.345

  13. Gupta S, Gupta V, Aggarwal PN, Kant R, Khurana N,Mandal AK. Primary chondrosarcoma of the breast: a casereport. Indian J Cancer. 2003;40(2):77-79.

  14. Verfaillie G, Breucq C, Perdaens C, Bourgain C, LamoteJ. Chondrosarcoma of the breast. Breast J. 2005;11(2):147-148. https://doi.org/10.1111/j.1075-122X.2005.21573.x

  15. Gurleyik E, Yildirim U, Gunal O, Pehlivan M. Malignantmesenchymal tumor of the breast: primary chondrosarcoma.Breast Care (Basel). 2009;4(2):101-103. https://doi.org/10.1159/000212101

  16. De Padua M, Bhandari TP. Primary mesenchymal chondrosarcomaof the breast. Indian J Pathol Microbiol.2009;52(1):129-130. https://doi.org/cwr8tt

  17. Lakshmikantha A, Kawatra V, Varma D, Khurana N.Primary breast chondrosarcoma. Breast J. 2010;16(5):553-554. https://doi.org/10.1111/j.1524-4741.2010.00960.x

  18. Patterson JD, Wilson JE, Dim D, Talboy GE. Primarychondrosarcoma of the breast: report of a case and reviewof the literature. Breast Dis. 2011;33(4):189-191. https://doi.org/10.3233/BD-2009-0303

  19. Badyal RK, Kataria AS, Kaur M. Primary chondrosarcomaof male breast: a rare case. Indian J Surg. 2012;74:418-419.https://doi.org/10.1007/s12262-012-0439-2

  20. Mujtaba SS, Haroon S, Faridi N. Primary chondrosarcomaof breast. J Coll Physicians Surg Pak. 2013;23(10):754-755.

  21. Errarhay S, Fetohi M, Mahmoud S, Saadi H, BouchikhiC, Banani A. Primary chondrosarcoma of the breast: acase presentation and review of the literature. World JSurg Oncol. 2013;11:208. https://doi.org/10.1186/1477-7819-11-208

  22. Sinhasan SP, Bharathi KV, Bhat RV, Dasiah SD. Primarychondrosarcoma of breast—cytology with histopathologicalcorrelation: a rare case report with review of literature.Indian J Pathol Microbiol. 2014;57(2):311-313. https://doi.org/10.4103/0377-4929.134727

  23. Farahat A, Magdy N, Elaffandi A. Primary myxoidchondrosarcoma of the breast. Ann R Coll Surg Engl.2014;96(1):112E-114E. https://doi.org/10.1308/003588414X13824511649210

  24. Bagri PK, Beniwal S, Sharma A. Malignant mesenchymaltumor of male breast: primary chondrosarcoma. Iran JCancer Prev. 2015;8(1):63-65.

  25. Pasta V, Sottile D, Urciuoli P, Del Vecchio L, CustureriF, D’Orazi V. Rare chondrosarcoma of the breast treatedwith quadrantectomy instead of mastectomy: a case report.Oncol Lett. 2015;9(3):1116-1120. https://doi.org/10.3892/ol.2014.2803

  26. Militello G, Zabbia G, Mascolino A, Kabhuli K, GulottaE, De Marco P, Incandela F, Scerrino G, GulottaG. Skin nipple sparing mastectomy: the first approach inprimary myxoid chondrosarcoma of the breast. Int J SurgCase Rep. 2017;34:130-133. https://doi.org/10.1016/j.ijscr.2017.03.016

  27. Amadu AM, Soro D, Marras V, Satta G, Crivelli P, ContiM, Meloni GB. Primary breast chondrosarcoma: imagingand pathological findings. Eur J Radiol Open. 2017;4:138-140. https://doi.org/10.1016/j.ejro.2017.11.001

  28. Cong Y, Fang X, Qiao G, Zou H, Lin J, Zhu S. Primaryextraskeletal myxoid chondrosarcoma with adenofibromaof the breast: a case report and literature review. Int J ClinExp Med. 2018;11(4):4317-4323.

  29. Rao L, Kudva R, Rao RV, Kumar B. Extraskeletal myxoidchondrosarcoma of the chest wall masquerading as abreast tumor: a case report. Acta Cytol. 2002;46(2):417-421. https://doi.org/10.1159/000326743

  30. Łukasiewicz E, Ziemiecka A, Jakubowski W, Vojinovic J,Bogucevska M, Dobruch-Sobczak K. Fine-needle versuscore-needle biopsy—which one to choose in preoperativeassessment of focal lesions in the breasts? Literature review.J Ultrason. 2017;17(71):267-274. https://doi.org/10.15557/JoU.2017.0039

  31. Reddy TP, Rosato RR, Li X, Moulder S, Piwnica-WormsH, Chang JC. A comprehensive overview of metaplasticbreast cancer: clinical features and molecular aberrations.Breast Cancer Res. 2020;22:121. https://doi.org/10.1186/s13058-020-01353-z

  32. Pernick N. S-100 stain. En: PathologyOutlines.com [Internet].Bingham Farms (MI): PathologyOutlines LLC;[cited 2026 Jan 18]. Available from: https://www.pathologyoutlines.com/topic/stainss100.html

  33. Pernick N. Vimentin stain. En: PathologyOutlines.com[Internet]. Bingham Farms (MI): PathologyOutlines LLC;[cited 2026 Jan 18]. Available from: https://www.pathologyoutlines.com/topic/stainsvimentin.html

  34. Tang CH. Molecular mechanisms of chondrosarcomametastasis. J Cell Mol Med. 2013;17(1):1-4. https://doi.org/10.1111/jcmm.12002

  35. Cates JMM. The AJCC 8th edition staging system forsoft tissue sarcoma of the extremities or trunk: a cohortstudy of the SEER database. J Natl Compr CancNetw. 2018;16(2):144-152. https://doi.org/10.6004/jnccn.2017.7042

  36. American Cancer Society. Soft tissue sarcoma stages [Internet].Atlanta (GA): American Cancer Society; [cited2026 Jan 17]. Available from: https://www.cancer.org/cancer/types/soft-tissue-sarcoma/detection-diagnosis-staging/staging.html

  37. Dangoor A, Seddon B, Gerrand C, Grimer R, Whelan J,Judson I. UK guidelines for the management of soft tissuesarcomas. Clin Sarcoma Res. 2016;6:20. https://doi.org/10.1186/s13569-016-0060-4

  38. National Comprehensive Cancer Network. Soft tissue sarcomaNCCN evidence blocks version 1.2025 [Internet].Plymouth Meeting (PA): NCCN; 2025 [cited 2026 Feb 4].Available from: https://tinyurl.com/2xhw9u7k




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Fac Med UNAM . 2026;69